Here we measured the frequencies and suppressive function of Treg in PB, BM and involved lymphatic tissues of patients with B-cell NHL and determined whether malignant B cells could induce the conversion of Treg from CD4+CD25− T cells. The gene discussed is CD4; the disease is B-cell non-Hodgkin lymphoma.